Thailand is developing its own anti-coronavirus vaccine

December 28, 2020
  1. Home
  2. /
  3. News center
  4. /
  5. Biotech News
  6. /
  7. Thailand
  8. /
  9. Covid-19
  10. /
  11. Thailand is developing its...
December 28, 2020 Supachai

Thailand is developing its own anti-coronavirus vaccine

A DNA vaccine effort by Thailand-based BioNet-Asia is expected to start its first phase of human trials in Australia early 2021

Thailand wants to inoculate about 50% of its population by next year. It plans to get 26 million doses from the World Health Organization-backed Covax program, 26 million from AstraZeneca, and 13 million more from other sources, providing immunity to more than 30 million people. Not wanting to rely solely on inoculations from abroad, Thailand is also developing its own anti-coronavirus shot.

  • An mRNA vaccine research project is set to start the first phase of clinical trials in April and the second phase in June. The vaccines may be available by end-2021 after receiving emergency-use authorization
  • A DNA vaccine effort by Thailand-based BioNet-Asia is expected to start its first phase of human trials in Australia early 2021

Mid-2021: AstraZeneca

  • Thailand has an advance agreement with AstraZeneca to secure Covid-19 vaccines, which are expected to be approved and produced by mid-2021, Prime Minister Prayuth Chan-Ocha said
  • Thailand may receive vaccine doses by mid-2021 and these are expected to be distributed from then
  • Under agreement with AstraZeneca, Siam Bioscience will produce vaccines at its facilities, and Thailand will receive technology transfer
  • Thailand will supply coronavirus vaccines at “reasonable prices” to Myanmar, Laos, Cambodia and Vietnam when it begins production, Prayuth said.
, , ,